摘要
Objective To compare the efficacy and safety between twice- and triple-daily subcutaneous injection of premixed insulin aspart 30 ( BIAsp30) in serious T2DM patients with failure of oral anti-diabetic drugs(OADs) . Methods Fifty-six patients with inadequate control of hyper-glycemia by OADs were randomized into two